Morgan Stanley Discount Zert TEVA.../ DE000ME8V950 /
| 2024-05-17 6:08:55 PM | Chg.-0.08 | Bid10:00:35 PM | Ask10:00:35 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 13.06EUR | -0.61% | - Bid Size: - |
- Ask Size: - |
Teva Pharmaceutical ... | - USD | 2024-09-27 | Call |
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Merger between WideOp...
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx B...
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire
05-17
LAWSUIT ANNOUNCEMENT: BFA Law Encourages Sprout Social Investors to Contact the Firm About the Pendi...
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Buyout of Squarespac...
GlobeNewswire
05-14
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc....
GlobeNewswire
05-14
SPROUT SOCIAL, INC. LITIGATION ALERT (NASDAQ: SPT): Sprout Social Sued For Violations of the Federal...
GlobeNewswire
05-14
CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire
05-14
SQUARESPACE, INC. (NYSE: SQSP) SHAREHOLDER ALERT: Squarespace is Being Investigated In Connection Wi...
GlobeNewswire
05-14
Leading Law Firm Bleichmar Fonti & Auld LLP announces an investigation of WideOpenWest, Inc.’s (NYSE...
GlobeNewswire
05-13
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...
GlobeNewswire
05-11
VENTYX BIOSCIENCES, INC. INVESTOR ALERT (NASDAQ: VTYX): The Directors of Ventyx Biosciences, Inc. Ar...
GlobeNewswire
05-11
SPROUT SOCIAL, INC. STOCK DROP ALERT (NASDAQ: SPT): Sprout Social Stock Falls After Earnings; Top La...
GlobeNewswire
04-30
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire
04-24
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire
04-19
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire
04-16
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire
03-20
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
